Recruiting Alpha-1 Antitrypsin Deficiency Studies in Boston
Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema
Phase 2 open label extension study to evaluate SAR447537 (INBRX-101) in adults with AATD emphysema...
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
The liver produces a protein called alpha-1 antitrypsin (AAT). AAT is normally released into the bloodstream. In some people, the liver makes an abnormal version of the AAT protein, called Z-AAT. Maki...
About Alpha-1 Antitrypsin Deficiency Clinical Trials in Boston
Alpha-1 antitrypsin deficiency is a genetic condition that increases the risk of lung and liver disease due to low levels of the protective protein alpha-1 antitrypsin. It is one of the most common genetic causes of COPD. Treatment includes augmentation therapy and management of lung and liver symptoms.
There are currently 2 alpha-1 antitrypsin deficiency clinical trials recruiting participants in Boston, MASSACHUSETTS. These studies are seeking a combined 235 participants. Research is being sponsored by Sanofi, Takeda. Clinical trial participation is free and participants receive study-related medical care at no cost.
Alpha-1 Antitrypsin Deficiency Clinical Trials in Boston — FAQ
Are there alpha-1 antitrypsin deficiency clinical trials in Boston?
Yes, there are 2 alpha-1 antitrypsin deficiency clinical trials currently recruiting in Boston, MASSACHUSETTS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Boston?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you about next steps.
Are clinical trials in Boston free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boston studies also compensate for your time and travel.
What alpha-1 antitrypsin deficiency treatments are being tested?
The 2 active trials in Boston are testing new therapies including novel drugs, biologics, and treatment approaches for alpha-1 antitrypsin deficiency.
Data updated March 2, 2026 from ClinicalTrials.gov